Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Prolidase Enzyme Activity as a Diagnostic Marker for Acute Ischemic Stroke

NCT03334968 is registered in ClinicalTrials.gov with Bezmialem Vakif University as lead sponsor.

NCT NCT03334968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03334968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Prolidase Enzyme Activity as a Diagnostic Marker for Acute Ischemic Stroke
Lead sponsor
Bezmialem Vakif University
Phase
Observational
Overall status
Completed
Start date
May 1, 2016
Completion date
May 1, 2017
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prolidase deficiency, stroke, ischemic